Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23674151 | 1.00 | PSMB5 (0.40) | PSMB5MCHR1PDE10AKDM4ES1PR1 | |
| SCHEMBL23674080 | 0.93 | PSMB5 (0.49) | PSMB5MCHR1KDM4ES1PR1S1PR3 | |
| SCHEMBL23674057 | 0.92 | PSMB5 (0.46) | PSMB5MCHR1KDM4ES1PR1S1PR3 | |
| SCHEMBL29980305 | 0.92 | PSMB5 (0.46) | PSMB5MCHR1KDM4ES1PR1S1PR3 | |
| SCHEMBL23674015 | 0.92 | FFAR1 (0.40) | MCHR1S1PR1S1PR3PPARG | |
| SCHEMBL29980354 | 0.92 | FFAR1 (0.40) | MCHR1S1PR1S1PR3PPARG | |
| SCHEMBL23674043 | 0.91 | PSMB5 (0.45) | PSMB5KDM4ES1PR1S1PR3PPARG | |
| SCHEMBL23674178 | 0.91 | PTGER2 (0.42) | MCHR1PDE10APPARGPTGER2EGFR | |
| SCHEMBL23674048 | 0.91 | PSMB5 (0.45) | PSMB5KDM4ES1PR1S1PR3PPARG | |
| SCHEMBL23674021 | 0.91 | PSMB5 (0.45) | PSMB5KDM4ES1PR1S1PR3PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115209883-B | Novel cell metabolism regulating compound and use thereof | 新月生物科学 | 2025-05-20 | — | — | CN | claimed |
| CN-116615189-A | Novel cell metabolism regulating compounds and their use for the treatment of viral diseases | 新月生物科学 | 2023-08-18 | — | — | CN | claimed |
| EP-4093384-A1 | NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF | Crescenta Biosciences (US) | 2022-11-30 | — | — | EP | claimed |
| CN-115209883-A | Novel cell metabolism-regulating compounds and uses thereof | 新月生物科学 | 2022-10-18 | — | — | CN | claimed |
| CN-116615189-A | Novel cell metabolism regulating compounds and their use for the treatment of viral diseases | 新月生物科学 | 2023-08-18 | — | — | CN | disclosed |
| US-20230183179-A1 | NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF | CRESCENTA BIOSCIENCES (US) | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183179-A1 | NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF | FABP4, FABP1, FABP3 | PSMB5 4189/4885MCHR1 4236/4885PDE10A 3417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.